| # | Drug | Count |
|---|---|---|
| 0 | LETROZOLE | 67 |
| 1 | LETROZOLE TABLETS | 58 |
| 2 | CAPECITABINE | 50 |
| 3 | CYCLOPHOSPHAMIDE | 45 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 45 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 45 |
| 6 | FULVESTRANT | 45 |
| 7 | ANASTROZOLE | 36 |
| 8 | EVEROLIMUS | 36 |
| 9 | EXEMESTANE | 34 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TISLELIZUMAB-JSGR | 1 | 0.0045 |
| 1 | TRASTUZUMAB-DKST | 1 | 0.0036 |
| 2 | IXABEPILONE | 3 | 0.0029 |
| 3 | SODIUM MONOFLUOROPHOSPHATE | 1 | 0.0027 |
| 4 | TOREMIFENE CITRATE | 1 | 0.0023 |
| 5 | CARMUSTINE | 10 | 0.0021 |
| 6 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 2 | 0.0020 |
| 7 | EXEMESTANE | 34 | 0.0016 |
| 8 | PENICILLIN G POTASSIUM | 1 | 0.0014 |
| 9 | FULVESTRANT | 45 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Aromatase Inhibitor [EPC] | 98 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 82 |
| 2 | Kinase Inhibitor [EPC] | 75 |
| 3 | Alkylating Drug [EPC] | 50 |
| 4 | Estrogen Receptor Antagonist [EPC] | 46 |
| 5 | Microtubule Inhibitor [EPC] | 46 |
| 6 | Platinum-based Drug [EPC] | 45 |
| 7 | mTOR Inhibitor Immunosuppressant [EPC] | 35 |
| 8 | Corticosteroid [EPC] | 32 |
| 9 | HER2/neu Receptor Antagonist [EPC] | 31 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 46 | 0.0011 |
| 1 | Aromatase Inhibitor [EPC] | 98 | 0.0009 |
| 2 | HER2/neu Receptor Antagonist [EPC] | 31 | 0.0004 |
| 3 | Calcitonin [EPC] | 1 | 0.0003 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 82 | 0.0003 |
| 5 | Microtubule Inhibitor [EPC] | 46 | 0.0003 |
| 6 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 5 | 0.0002 |
| 7 | Alkylating Drug [EPC] | 50 | 0.0002 |
| 8 | Platinum-based Drug [EPC] | 45 | 0.0002 |
| 9 | Topoisomerase Inhibitor [EPC] | 12 | 0.0002 |